Business Context and Reporting Period
This Form 8-K is a current report filed by AngioDynamics, Inc. on January 13, 2016. The filing serves to disclose a presentation made by Joseph M. DeVivo, President and CEO, to investors at the JP Morgan 34th Annual Healthcare Conference on the same date.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a presentation event rather than a financial statement.
Material Changes
No material changes to financial results or operations are reported in this document. The filing solely references the dissemination of conference slides (Exhibit 99.1) which are not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Guidance, Outlook, and Risks
The document contains a comprehensive "Forward-Looking Statements" section. It warns that statements regarding future financial position, results of operations, and business strategy are not guarantees. Key risks and uncertainties identified include:
- Product development and technological advances by competitors.
- Intellectual property infringement claims.
- Regulatory actions by the FDA and other agencies.
- Healthcare reforms and government regulations.
- Results of clinical trials and ongoing litigation.
- Product recalls and liability claims.
- Foreign currency exchange rate fluctuations.
- Integration of purchased businesses.
Management explicitly states it does not assume an obligation to update or revise forward-looking statements.
Key Facts for Investor Verification
- Verify the content of the presentation slides (Exhibit 99.1) referenced in this filing, as they contain the actual strategic and financial commentary.
- Review the company's most recent Form 10-K (year ended May 31, 2015) and Form 10-Q (periods ended August 31, 2015, and November 30, 2015) for detailed financial data and risk factors.
- Note that the information in the conference slides is not incorporated by reference into other SEC filings.